About
Moshe "Mori" Arkin is an Israeli billionaire entrepreneur and investor. He founded Arkin Holdings, a pharmaceutical company, and Arkin Capital, a multi-stage investment manager with over $2 billion under management focused on biotech, healthcare, and related sectors. Arkin Holdings was founded in 2009 as his primary investment vehicle, directing significant capital toward life sciences ventures, emphasizing biotechnology and pharmaceutical innovations. His strategy focuses on early- to mid-stage companies developing novel therapies, with investments spanning oncology, rare diseases, and infectious disease treatments. Arkin Capital has expanded into digital health, private equity, technology, and real estate, backed by institutional investors and emphasizing global portfolio growth. Mori Arkin's wealth primarily derives from his ventures in the pharmaceutical industry, including the 2004 sale of Agis Industries to Perrigo for $818 million.
Portfolio
Investment activity
1 portfolio exit on record.
Portfolio by sector
Q&A
- What is Mori Arkin's primary investment focus based on recent portfolio activity?
- Mori Arkin's recent portfolio activity shows a focus on Agriculture & Food Technologies and Health Tech & Life Sciences, with two companies in each sector. Additionally, there is one company in Industrial Technologies.
- Which notable companies are in Mori Arkin's current portfolio?
- Mori Arkin's portfolio includes Butterfly Medical, which develops an implantable device for nonsurgical BPH treatment, and OdysightAI, focused on visual sensing and video-based predictive maintenance systems.
- Has Mori Arkin had any notable exits recently?
- Yes, Mori Arkin had an exit in August 2021 with TopGum Industries, a company producing functional, sugar-free gummy supplements, which went public on the TASE with a valuation of $165.79M.
- What is Mori Arkin's investment stage preference?
- Mori Arkin has participated in various stages, including an A Round, a B Round, Convertible Debt, and PIPE rounds.
- Can you provide an example of a recent investment by Mori Arkin?
- In March 2023, Mori Arkin invested in Phytolon, a company focused on the production of natural food colorants, which raised $20.25M in its Series A round.
- What is Mori Arkin's role within Arkin Capital?
- Mori Arkin is the chairman of Arkin Capital. The investments listed reflect past activities of Arkin Holding before its reorganization into different entities like Arkin Digital Health, Arkin Bio, Arkin Tech, and Arkin Equity.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2009 |
|---|
Radar intelligence
Patents
| EPO | 1 |
|---|